Learn about pharmaceutical company compliance requirements in Turkey in 2026. Discover licensing obligations, GMP compliance, pharmacovigilance requirements, GDP standards, pharmaceutical advertising rules, regulatory inspections, product safety obligations, and legal requirements for pharmaceutical companies.

Turkey has one of the most highly regulated pharmaceutical sectors in the region. Pharmaceutical companies operating in Turkey must comply with a comprehensive legal framework governing drug licensing, manufacturing, importation, distribution, marketing, pharmacovigilance, product safety, clinical trials, data protection, and healthcare compliance. The Turkish pharmaceutical market continues to attract domestic and foreign investors due to its large population, advanced healthcare infrastructure, growing healthcare expenditure, and strategic location connecting Europe, Asia, and the Middle East.

However, the pharmaceutical sector is subject to intensive oversight by regulatory authorities. Pharmaceutical companies are expected to maintain continuous compliance throughout the entire product lifecycle, from licensing and manufacturing to distribution, post-market surveillance, and product recalls. Compliance failures may result in administrative fines, suspension of activities, product withdrawals, license cancellations, reputational damage, and significant legal liability.

This 2026 Legal Guide explains the most important compliance requirements applicable to pharmaceutical companies operating in Turkey.

The Regulatory Authority Governing Pharmaceutical Companies

The primary regulatory authority overseeing pharmaceutical activities in Turkey is the Turkish Medicines and Medical Devices Agency (TITCK), operating under the Ministry of Health.

TITCK is responsible for:

• Pharmaceutical Licensing
• Manufacturing Oversight
• Import and Export Controls
• Distribution Regulation
• Clinical Trial Authorization
• Pharmacovigilance Monitoring
• Product Recalls
• Regulatory Inspections
• Advertising Supervision

The agency supervises the entire pharmaceutical supply chain and possesses extensive enforcement powers regarding compliance violations.

Pharmaceutical Company Formation Requirements

Foreign and domestic investors may establish pharmaceutical companies in Turkey through standard corporate structures.

Common structures include:

• Limited Liability Companies (LLC)
• Joint Stock Companies (JSC)
• Pharmaceutical Holding Companies
• Healthcare Joint Ventures
• Distribution Companies

Although company formation follows general corporate procedures, pharmaceutical activities frequently require additional regulatory approvals before operations may commence. Corporate registration alone does not authorize pharmaceutical activities.

Pharmaceutical Licensing Obligations

One of the most important compliance requirements concerns pharmaceutical product licensing.

Before a medicinal product may be placed on the Turkish market, authorization from TITCK is generally required.

The licensing process typically evaluates:

• Product Quality
• Product Safety
• Clinical Efficacy
• Manufacturing Standards
• Supply Chain Documentation
• Technical Dossiers

Licensing should not be viewed as a one-time approval. Compliance obligations continue after market authorization and remain applicable throughout the product’s commercial lifecycle.

Good Manufacturing Practice (GMP) Compliance

Pharmaceutical manufacturers must comply with Good Manufacturing Practice (GMP) requirements.

GMP systems generally cover:

• Quality Management
• Production Controls
• Personnel Qualifications
• Facility Standards
• Equipment Validation
• Documentation Systems
• Quality Assurance Procedures
• Corrective Actions

Manufacturing facilities are subject to inspections and ongoing regulatory monitoring.

Failure to maintain GMP compliance may lead to manufacturing restrictions, suspension of production activities, or product-related regulatory actions.

Good Distribution Practice (GDP) Requirements

Distribution activities are subject to Good Distribution Practice (GDP) standards.

GDP requirements generally focus on:

• Storage Conditions
• Transportation Controls
• Product Traceability
• Recall Systems
• Supply Chain Security
• Documentation Procedures
• Quality Management Systems

The Turkish regulatory authority has issued detailed guidance regarding GDP inspections and compliance expectations for pharmaceutical distributors. GDP inspections are designed to ensure proper storage, transportation, and distribution of medicinal products.

Pharmacovigilance Compliance

Pharmacovigilance is one of the most important post-market obligations facing pharmaceutical companies.

Pharmacovigilance systems generally involve:

• Adverse Event Monitoring
• Safety Reporting
• Risk Management
• Product Safety Assessments
• Regulatory Reporting
• Post-Marketing Surveillance

Pharmaceutical companies are expected to maintain systems capable of identifying, evaluating, and reporting product safety concerns throughout the life of a medicinal product. Post-licensing pharmacovigilance remains a central component of regulatory compliance.

Import and Export Compliance

Pharmaceutical companies involved in international trade must comply with additional regulatory requirements.

These may include:

• Import Authorizations
• Export Controls
• Customs Compliance
• Product Registration Requirements
• Supply Chain Documentation
• Cross-Border Distribution Controls

International pharmaceutical transactions are subject to both healthcare regulations and customs legislation.

Proper regulatory planning is essential before engaging in cross-border pharmaceutical activities.

Product Safety and Liability Obligations

Product safety obligations continue throughout the product lifecycle.

Under Turkish legislation, manufacturers and importers may face liability for unsafe products that cause harm to individuals or property.

Compliance obligations typically include:

• Product Monitoring
• Safety Reporting
• Recall Procedures
• Corrective Actions
• Risk Assessments
• Consumer Protection Measures

Regulatory approval does not automatically eliminate potential liability arising from defective pharmaceutical products.

Pharmaceutical Advertising and Promotion Rules

Advertising and promotional activities are strictly regulated.

Pharmaceutical companies must ensure that:

• Promotional Materials Are Accurate
• Approved Indications Are Used
• Misleading Claims Are Avoided
• Healthcare Professional Interactions Comply With Regulations
• Marketing Activities Follow Regulatory Standards

Off-label promotion and unauthorized advertising activities may trigger regulatory investigations and administrative sanctions.

Clinical Trial Compliance

Companies conducting clinical research must comply with strict regulatory requirements.

Clinical trial obligations may include:

• Ethics Committee Approvals
• Regulatory Authorizations
• Participant Protection Measures
• Insurance Requirements
• Safety Monitoring
• Data Collection Standards

Unauthorized clinical trials may result in significant legal consequences.

Clinical trial compliance remains a major area of regulatory scrutiny.

Data Protection and Patient Privacy

Pharmaceutical companies frequently process sensitive health-related information.

Compliance obligations generally include:

• Patient Confidentiality
• Personal Data Protection
• Cybersecurity Controls
• Data Retention Policies
• Information Security Procedures

Healthcare-related data is often subject to enhanced protection requirements.

Comprehensive privacy compliance programs are essential for pharmaceutical businesses.

Regulatory Inspections and Audits

Pharmaceutical companies should expect periodic inspections and audits.

Regulatory reviews may focus on:

• GMP Compliance
• GDP Compliance
• Pharmacovigilance Systems
• Product Documentation
• Quality Management Systems
• Distribution Activities
• Promotional Activities

Authorities possess broad inspection powers and may impose sanctions for identified deficiencies.

Product Recall Obligations

Pharmaceutical companies must maintain effective recall procedures.

Recall systems should enable businesses to:

• Identify Affected Products
• Trace Distribution Channels
• Notify Authorities
• Remove Products Efficiently
• Protect Patient Safety

Regulators expect companies to implement robust traceability and recall mechanisms throughout the supply chain.

Common Compliance Risks

The most common compliance challenges include:

• Licensing Violations
• GMP Deficiencies
• GDP Failures
• Pharmacovigilance Reporting Errors
• Advertising Violations
• Data Protection Breaches
• Product Recall Failures
• Documentation Deficiencies
• Import Compliance Issues
• Regulatory Inspection Findings

Most risks can be significantly reduced through proactive compliance programs and internal audits.

Why Legal Assistance Is Essential

The pharmaceutical industry operates within one of the most complex regulatory environments in Turkey.

Professional legal support can assist with:

• Pharmaceutical Licensing
• Regulatory Compliance
• GMP and GDP Reviews
• Pharmacovigilance Programs
• Clinical Trial Compliance
• Advertising Reviews
• Product Recall Management
• Regulatory Investigations
• Compliance Audits
• Pharmaceutical Litigation

Early legal guidance can significantly reduce regulatory risks and protect long-term business operations.

Frequently Asked Questions (FAQ)

1. Can foreign investors establish pharmaceutical companies in Turkey?

Yes. Foreign investors may establish pharmaceutical companies through Turkish corporate structures, subject to applicable pharmaceutical regulations.

2. Which authority regulates pharmaceutical companies?

The Turkish Medicines and Medical Devices Agency (TITCK) is the primary regulatory authority overseeing pharmaceutical activities.

3. Is pharmaceutical licensing mandatory?

Yes. Medicinal products generally require regulatory authorization before being placed on the market.

4. What is GMP compliance?

Good Manufacturing Practice (GMP) regulates pharmaceutical manufacturing quality systems and production standards.

5. What is GDP compliance?

Good Distribution Practice (GDP) governs pharmaceutical storage, transportation, and distribution activities.

6. What is pharmacovigilance?

Pharmacovigilance involves monitoring, evaluating, and reporting medicine safety information after products enter the market.

7. Can pharmaceutical companies advertise products freely?

No. Pharmaceutical advertising and promotional activities are heavily regulated.

8. Are pharmaceutical companies subject to inspections?

Yes. Regulatory authorities conduct inspections regarding manufacturing, distribution, quality systems, and compliance programs.

9. What are the biggest compliance risks?

Licensing violations, GMP deficiencies, pharmacovigilance failures, GDP non-compliance, advertising violations, and data protection breaches.

10. Why should pharmaceutical companies work with specialized lawyers?

Legal guidance helps companies maintain compliance, reduce regulatory risks, respond to inspections, and protect long-term business interests.

LEGAL SUPPORT FOR PHARMACEUTICAL COMPANIES IN TURKEY

The pharmaceutical industry presents significant opportunities for investors, manufacturers, distributors, healthcare companies, and international life sciences businesses. However, successful participation in the pharmaceutical sector requires careful regulatory planning, ongoing compliance management, and effective risk mitigation strategies.

Whether you are establishing a pharmaceutical company, applying for product licenses, implementing GMP or GDP systems, launching distribution operations, conducting clinical research, managing pharmacovigilance obligations, or expanding pharmaceutical activities into Turkey, professional legal support can help protect your investment and ensure compliance with evolving regulatory requirements.

CONTACT FIRAT FESIH KAYA LAW FIRM

Phone: +90 312 434 22 22

Mobile Phone: +90 532 769 22 22

E-mail: info@firatfesihkaya.av.tr

Address: Mevlana Boulevard No:221, Yildirim Tower No:148, 06520 Balgat, Cankaya, Ankara, Turkey

Our law firm provides comprehensive legal services for pharmaceutical companies, healthcare investors, manufacturers, distributors, medical device companies, biotechnology businesses, healthcare technology providers, and multinational life sciences organizations operating in Turkey.